Abstract
Purpose
To investigate the outcomes of initial-onset acute uveitis associated with Vogt–Koyanagi–Harada (VKH) disease that occurred during pregnancy.
Methods
This is a retrospective case series.
Results
During the period between January 2001 and December 2021, we identified 112 patients with initial-onset acute uveitis associated with VKH disease, 67 (59.8%) were females. Among the female patients, 10 (14.9%) patients (20 eyes) were pregnant. Of these patients, 5 patients presented in the first trimester, 3 in the second trimester and 2 in the third trimester. The follow-up period ranged from 8 to 108 months (mean 35.2 ± 28.3 months). At presentation, 8 (80%) patients had initial-onset acute VKH disease with anterior segment (AS) inflammation and 2 (20%) initial-onset acute VKH disease without AS inflammation. All patients were initially treated with systemic corticosteroids combined with cyclosporine. During follow-up period, none of the patients with initial-onset acute VKH disease without AS inflammation developed any complications. Complications including "sunset glow fundus" in 8 (40%) eyes, cataract in 2 (10%) eyes and subretinal fibrosis in 1 (5%) eye were recorded in patients with initial-onset acute VKH disease with AS inflammation. Four (40%) patients developed pregnancy-related complications, including abortion in 1 patient, systemic hypertension in 1 patient and premature rupture of membrane in 2 patients. There were no documented congenital anomalies in all born babies. Best-corrected visual acuity of ≥ 20/20 was achieved in 16 (80%) eyes at the final follow-up.
Conclusion
Primary treatment with combined systemic corticosteroids and cyclosporine in initial-onset acute uveitis associated with VKH disease was safe and effective.
Similar content being viewed by others
References
Gocho K, Kondo I, Yamaki K (2001) Identification of autoreactive T cells in Vogt–Koyanagi–Harada disease. Invest Ophthalmol Vis Sci 42:2004–2009
Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S (2000) Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 165:7323–7329. https://doi.org/10.4049/jimmunol.165.12.7323
Yamaki K, Kondo I, Nakamura H, Miyano M, Konno S, Sakuragi S (2000) Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats. Exp Eye Res 71:361–369. https://doi.org/10.1006/exer.2000.0893
Fang W, Yang P (2008) Vogt–Koyanagi–Harada syndrome. Curr Eye Res 33:517–523. https://doi.org/10.1080/02713680802233968
Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A (2007) Clinical characteristics of Vogt–Koyanagi–Harada syndrome in Chinese patients. Ophthalmology 114:606–614. https://doi.org/10.1016/j.ophtha.2006.07.040
Abu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D (2013) Prognostic factors for clinical outcomes in patients with Vogt–Koyanagi–Harada disease treated with high-dose corticosteroids. Acta Ophthalmol 91:e486–e493. https://doi.org/10.1111/aos.12127
Park YJ, Park KH, Woo SJ (2017) Clinical features of pregnancy-associated retinal and choroidal diseases causing acute visual disturbance. Korean J Ophthalmol 31:320–327. https://doi.org/10.3341/kjo.2016.0080
El-Asrar AM, Struyf S, Kangave D, Al-Obeidan SS, Opdenakker G, Geboes K, Van Damme J (2011) Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis. Clin Immunol 139:177–184. https://doi.org/10.1016/j.clim.2011.01.014
Abu El-Asrar AM, Berghmans N, Al-Obeidan SA, Mousa A, Opdenakker G, Van Damme J, Struyf S (2016) The cytokine interleukin-6 and the chemokines CCL20 and CXCL13 are novel biomarkers of specific endogenous uveitic entities. Invest Ophthalmol Vis Sci 57:4606–4613. https://doi.org/10.1167/iovs.16-19758
Abu El-Asrar AM, Struyf S, Van den Broeck C, Van Damme J, Opdenakker G, Geboes K, Kestelyn P (2007) Expression of chemokines and gelatinase B in sympathetic ophthalmia. Eye (Lond) 21:649–657. https://doi.org/10.1038/sj.eye.6702342
Buyon JP, Nelson JL, Lockshin MD (1996) The effects of pregnancy on autoimmune diseases. Clin Immunol Immunopathol 78:99–104. https://doi.org/10.1006/clin.1996.0018
Wilder RL (1998) Hormones, pregnancy, and autoimmune diseases. Ann N Y Acad Sci 840:45–50. https://doi.org/10.1111/j.1749-6632.1998.tb09547.x
Snyder DA, Tessler HH (1980) Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol 90:69–75
Steahly LP (1990) Vogt–Koyanagi–Harada syndrome and pregnancy. Ann Ophthalmol 22:59–62
Miyata N, Sugita M, Nakamura S, Isobe K, Matoba H, Tsuda K, Ohno S (2001) Treatment of Vogt–Koyanagi–Harada’s disease during pregnancy. Jpn J Ophthalmol 45:177–180. https://doi.org/10.1016/s0021-5155(00)00357-9
Doi M, Matsubara H, Uji Y (2000) Vogt–Koyanagi–Harada syndrome in a pregnant patient treated with high-dose systemic corticosteroids. Acta Ophthalmol Scand 78:93–96. https://doi.org/10.1034/j.1600-0420.2000.078001093.x
Sugita K, Mizumoto K, Kato N, Zako M (2015) Early resolution of subretinal fluid without high-dose corticosteroids in a pregnant patient with Vogt–Koyanagi–Harada disease: a case report. J Ophthalmic Inflamm Infect 5:20. https://doi.org/10.1186/s12348-015-0050-3
Nakamura T, Keino H, Okada AA (2018) Sub-tenon triamcinolone acetonide injection in a pregnant patient with Vogt–Koyanagi–Harada disease. Retin Cases Brief Rep 12:375–378. https://doi.org/10.1097/ICB.0000000000000510
Ingolotti M, Schlaen BA, Roig Melo-Granados EA, Ruiz Garcia H, Aguilera Partida JA (2019) Azathioprine During the First Trimester of Pregnancy in a Patient with Vogt–Koyanagi–Harada Disease: A Multimodal Imaging Follow-Up Study. Am J Case Rep 20:300–305. https://doi.org/10.12659/AJCR.914281
Nohara M, Norose K, Segawa K (1995) Vogt–Koyanagi–Harada disease during pregnancy. Br J Ophthalmol 79:94–95. https://doi.org/10.1136/bjo.79.1.94
Sato S, Tamaru H (1986) Incomplete type Harada’s disease in early pregnant stage treated with topical corticosteroid. Nippon Ganka Kiyo (Folia Ophthalmol Jpn) 37:46–50
Taguchi C, Ikeda E, Hikita N, Mochizuki M (1999) A report of two cases suggesting positive influence of pregnancy on uveitis activity. Nippon Ganka Gakkai Zasshi 103:66–71
Ohta K, Gotoh N, Yonezawa H, Oka K, Ashida T (2007) Fetal death following high-dose systemic steroid therapy in a pregnant patient with Vogt–Koyanagi–Harada disease. Nippon Ganka Gakkai Zasshi 111:959–964
Yamagami S, Mochizuki M, Ando K (1991) Systemic corticosteroid therapy for pregnant patients with Vogt–Koyanagi–Harada syndrome. Rinsho Ganka (Jpn J Clin Ophthalmol) 85:52–62
Watase S, Kawamura K, Iseki N (1995) A case of Harada disease during pregnancy treated with systemic corticosteroid drugs. Nippon Ganka Kiyo (Folia Ophthalmol Jpn) 46:1192–1195
Matsubara S, Kuwata T, Ohkawara Y, Makino S (2011) Headache in late pregnancy: a symptom for Vogt–Koyanagi–Harada disease. Arch Gynecol Obstet 283:1423–1425. https://doi.org/10.1007/s00404-010-1748-y
Wakefield D, Abu El-Asrar A, McCluskey P (2012) Treatment of severe inflammatory eye disease in patients of reproductive age and during pregnancy. Ocul Immunol Inflamm 20(4):277–287. https://doi.org/10.3109/09273948.2012.684736
Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature Working G (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516. https://doi.org/10.1016/j.ajo.2005.03.057
Buyon JP (1998) The effects of pregnancy on autoimmune diseases. J Leukoc Biol 63:281–287. https://doi.org/10.1002/jlb.63.3.281
Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME, Cutolo M, Tincani A, Todesco S (2006) Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol 22:234–241. https://doi.org/10.1016/j.reprotox.2006.04.001
Elenkov IJ, Hoffman J, Wilder RL (1997) Does differential neuroendocrine control of cytokine production govern the expression of autoimmune diseases in pregnancy and the postpartum period? Mol Med Today 3:379–383. https://doi.org/10.1016/s1357-4310(97)01089-7
Elenkov IJ, Wilder RL, Bakalov VK, Link AA, Dimitrov MA, Fisher S, Chrousos GP (2001) IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 86:4933–4938. https://doi.org/10.1210/jcem.86.10.7905
Keeling SO, Oswald AE (2009) Pregnancy and rheumatic disease: “by the book” or “by the doc.” Clin Rheumatol 28:1–9. https://doi.org/10.1007/s10067-008-1031-9
Jara LJ, Vera-Lastra O, Miranda JM, Alcala M, Alvarez-Nemegyei J (2001) Prolactin in human systemic lupus erythematosus. Lupus 10:748–756. https://doi.org/10.1191/096120301717164994
Ostensen M, Villiger PM, Forger F (2012) Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev 11:A437-446. https://doi.org/10.1016/j.autrev.2011.11.013
Rabiah PK, Vitale AT (2003) Noninfectious uveitis and pregnancy. Am J Ophthalmol 136:91–98. https://doi.org/10.1016/s0002-9394(03)00110-7
AlBloushi AF, Alfawaz AM, Al-Dahmash SA, Al Owaifeer AM, AlEnezi SH, Al-Fakhri AS, Abu El-Asrar AM (2019) Incidence, risk factors and surgical outcomes of cataract among patients with uveitis in a University Referral Hospital in Riyadh, Saudi Arabia. Ocul Immunol Inflamm 27:1105–1113. https://doi.org/10.1080/09273948.2018.1504970
Park YJ, Park KH, Woo SJ (2017) Clinical features of pregnancy-associated retinal and choroidal diseases causing acute visual disturbance. Korean J Ophthalmol 31(4):320–327. https://doi.org/10.3341/kjo.2016.0080
Friedman Z, Granat M, Neumann E (1980) The syndrome of Vogt–Koyanagi–Harada and pregnancy. Metab Pediatr Ophthalmol 4:147–149
Norose K, Yano A, Wang XC, Tokushima T, Umihira J, Seki A, Nohara M, Segawa K (1994) Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt–Koyanagi–Harada disease. Invest Ophthalmol Vis Sci 35:33–39
Stirrat GM (1994) Pregnancy and immunity. BMJ 308:1385–1386. https://doi.org/10.1136/bmj.308.6941.1385
Chiam NP, Lim LL (2014) Uveitis and gender: the course of uveitis in pregnancy. J Ophthalmol 2014:401915. https://doi.org/10.1155/2014/401915
Sammaritano LR, Bermas BL, Chakravarty EE et al (2020) American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol 72(4):529–556
Prieto-Peña D, Calderón-Goercke M, Adán A et al (2021) Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy. Clin Exp Rheumatol 39(1):105–114
Abu El-Asrar AM, Dosari M, Hemachandran S, Gikandi PW, Al-Muammar A (2017) Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of “sunset glow fundus” in initial-onset acute uveitis associated with Vogt–Koyanagi–Harada disease. Acta Ophthalmol 95:85–90. https://doi.org/10.1111/aos.13189
Armenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF (1994) National transplantation Pregnancy Registry–outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation 57:502–506
Acknowledgements
The study is supported by King Saud University through Vice Deanship of Research Chair, Dr. Nasser Al Rashid Research Chair in Ophthalmology (Abu El-Asrar MA), Riyadh, Saudi Arabia.
Funding
The study is supported by King Saud University through Vice Deanship of Research Chair, Dr. Nasser Al Rashid Research Chair in Ophthalmology (Abu El-Asrar MA), Riyadh, Saudi Arabia.
Author information
Authors and Affiliations
Contributions
AZA and AIA collected the data and wrote the manuscript. AFA, NFA and AMA interpreted and analyzed the data. All the authors critically edited the manuscript for intellectual content. All the authors read and approve the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study was performed in line with the principles of the Declaration of Helsinki and has been evaluated by the Institutional Review Board at King Abdulaziz University Hospital and deemed not to require ethics approval.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent to publish
Consent for publication was obtained.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Alromaih, A.Z., Almater, A.I., Albloushi, A.F. et al. Outcomes of initial-onset acute uveitis associated with Vogt–Koyanagi–Harada disease occurred during pregnancy. Int Ophthalmol 43, 185–195 (2023). https://doi.org/10.1007/s10792-022-02415-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-022-02415-1